Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 30 /hr
Hire Dr. LINDA M.
Mexico
USD 30 /hr
Pharmacology Researcher | Expert in Hepatocellular Carcinoma & Scientific Writing
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Technical Writing
Research
Scientific and Technical Research
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Image Analysis
Work Experience
Doctorante
Center for Research and Advanced Studies of the National Polytechnic Institute
January 2022 - Present ![]()
Doctoral Researcher in Pharmacology
CINVESTAV-IPN, Department of Pharmacology
January 2017 - Present
Education
Doctor of Science (PhD) in Pharmacology
CINVESTAV-IPN
February 2022 - Present
Certifications
Publications
JOURNAL ARTICLE
Linda Vanessa Márquez-Quiroga, Aline Barboza-López, Jose Y. Suárez-Castillo, Irina Cardoso-Lezama, Miguel Á. Fuentes-Figueroa, Eduardo E. Vargas-Pozada, Juan D. Rodriguez-Callejas, Erika Ramos-Tovar, Carolina Piña-Vázquez, Jaime Arellanes-Robledo, et al. (2025). Naringenin attenuates early hepatocarcinogenesis induced by a MASH model . Annals of Hepatology.
Irina Cardoso-Lezama, Miguel Á. Fuentes-Figueroa, Erika Ramos-Tovar, Linda V. Márquez-Quiroga, Arturo Ortiz-Fernández, Eduardo E. Vargas-Pozada, Jaime Arellanes-Robledo, Víctor Tsutsumi, Pablo Muriel (2023). Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway . Biochemical Pharmacology.
Linda Vanessa Márquez-Quiroga, Jaime Arellanes-Robledo, Verónica Rocío Vásquez-Garzón, Saul Villa-Treviño, Pablo Muriel (2022). Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma . Biochemical Pharmacology.